Palvella Therapeutics (NASDAQ:PVLA – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Saturday. A number of other research analysts also recently weighed in on PVLA. Chardan Capital raised their price objective on Palvella Therapeutics from $210.00 to […]

Meritage Homes (NYSE:MTH – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued to investors on Saturday. A number of other research analysts have also recently issued reports on MTH. The Goldman Sachs Group reaffirmed a “buy” rating and […]

AbbVie (NYSE:ABBV – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a report issued on Saturday. Other research analysts have also issued reports about the stock. William Blair reiterated an “outperform” rating on shares of AbbVie in a research note on Monday, March […]

Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) was downgraded by Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Saturday. Other equities research analysts have also recently issued reports about the company. Sanford C. Bernstein decreased their price target on Regeneron Pharmaceuticals from $925.00 to $921.00 […]

IQVIA (NYSE:IQV – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday. A number of other equities research analysts have also issued reports on IQV. Weiss Ratings reiterated a “hold (c)” rating on shares of IQVIA in […]

Bristol Myers Squibb (NYSE:BMY – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Saturday. Several other research analysts also recently commented on the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Bristol […]

Natera (NASDAQ:NTRA – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Saturday. NTRA has been the topic of a number of other reports. BTIG Research upped their target price on Natera from $230.00 to […]

American Resources (NASDAQ:AREC – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a note issued to investors on Saturday. Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of American Resources in a research note on Wednesday, January 21st. Four investment […]

Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Saturday. A number of other research firms have also commented on BIOX. Weiss Ratings restated a “sell (d-)” rating on […]

Affiliated Managers Group (NYSE:AMG – Get Free Report) was downgraded by Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued on Saturday. AMG has been the topic of several other research reports. The Goldman Sachs Group increased their target price on shares of Affiliated Managers Group from $300.00 […]

Agenus (NASDAQ:AGEN – Get Free Report) was downgraded by Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Sunday. Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Agenus in a research report on Monday, December 29th. Two equities research analysts have rated […]